Skip to content

Internet Explorer is no longer supported by this website.

For optimal browsing we recommend using Chrome, Firefox or Safari.
Heart icon (animated) heart icon (static)
Explore more Johnson & Johnson sites:
Our Company

Meaningful Innovation for Better Patient Outcomes

AdvaMed - Gary Pruden alt
Today's Top Reads Close

At Johnson & Johnson, we have a strong partnering model that has set us apart in harnessing innovation, wherever it resides. In our Medical Devices Group, that tradition has led to advances of novel products and technologies in key areas like general and specialized surgery, orthopaedics, cardiovascular disease, neurosurgery, and infection prevention. For us, innovation means identifying meaningful insights and building on those insights to deliver better patient outcomes, particularly in key medical areas like cancer, obesity and trauma.

Share expand

That’s why this week’s AdvaMed 2015 Med Tech conference is such an important opportunity for us to share our vision as a global leader in medical devices and a valued partner too. Through our trusted brands like Ethicon, DePuy Synthes, Biosense Webster and others, we are delivering products and solutions across the total care continuum to increase patient satisfaction, improve clinical outcomes and reduce costs. In the United States and globally, one way we are doing this is by streamlining our service models and combining our portfolio offerings to deliver total solutions across entire specialty procedures, such as Thoracic, Bariatric and Joints. We are also working with many U.S. hospital systems to realize significant health care efficiencies.

Share expand

As one of the most comprehensive devices businesses in the industry, Johnson & Johnson Medical Devices Companies is best suited to serve evolving customer needs, train more surgeons to improve standards of care, and treat more patients globally as access expands. We will continue to inspire industry standards when it comes to the medical devices innovation model and use those insights to better address the world’s most pressing unmet medical needs.

Gary Pruden is the Worldwide Chairman of Johnson & Johnson Medical Devices, a role he assumed in May 2015. Prior to this, Gary led the Global Surgery Group from 2012. Before that he was Worldwide Franchise Chairman for Ethicon and a member of the Medical Device and Diagnostics Group Operating Committee.

Back to top
You are now leaving The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.